A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor normal and high responders undergoing controlled ovarian stimulation for IVF

摘要

Clinical characteristics of patients subdivided in the three groups of expected poor responders (ePR), expected normal responders (eNR), and expected high responders (eHR). Considering all patients together, as well as within each subgroup, no significant difference between patients receiving either the CFα day 2 or the CFα day 4 regimen was observed for any variable